Return to The CPNP Perspective issue main page.< Previous Article  Next Article >

CPNP 2018 attendees have the opportunity to attend a pre-meeting workshop that will focus on Pharmacists on the Front-line of Medication Assisted Treatment for Opioid Use Disorder. The workshop will be offered on Sunday, April 22 from 7:45-11:30 AM.

Pharmacists are essential health care providers who are trained to recognize opioid overdose, opioid use disorder, and withdrawal syndromes. Integration of the pharmacist into medication assisted treatment (MAT) teams for opioid use disorders can help improve access and outcomes, while reducing the risk of relapse. When pharmacists partner with prescribers to provide MAT, pharmacists are able to take the lead in developing treatment plans, communicating with patients, improving adherence, monitoring patients, identifying treatment options, and performing tasks to alleviate prescriber burden.

This session will demonstrate different practice settings where psychiatric pharmacists partner with prescribers to provide care collaboratively for patients with substance use disorders. The learner will leave with knowledge of innovative ways to include pharmacists on the MAT interprofessional team and how to design and execute effective practice protocols. In addition, the learner will explore the pharmacists’ role in addressing controversies and challenges in providing MAT with regard to state and federal limitations. Pharmacists participating in this program will be able to:

  1. Evaluate the need and capacity for medication assisted treatment for opioid use disorder on the state and national levels.
  2. Compare outcomes from collaborations integrating pharmacists in the medication assisted treatment care team in different practice settings across the United States.
  3. Describe the barriers and benefits encountered in establishing a collaborative practice agreement with prescribers to provide medication assisted treatment.
  4. Engage legislators, professional pharmacy organizations, boards of medicine and pharmacy and other entities to promote the role of pharmacists in medication assisted treatment.


Christopher M. Jones, PharmD, MPH
Acting Associate Deputy Assistant Secretary (Science and Data Policy)
Office of the Assistant Secretary for Planning and Evaluation, HHS
Washington, DC

Dr. Christopher M. Jones currently serves as Acting Associate Deputy Assistant Secretary for Science and Data Policy in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the US Department of Health and Human Services. The Office of Science and Data Policy is the HHS focal point for policy research, analysis, evaluation, and coordination of public health, science, and data policy activities, and provides authoritative advice and analytical support to HHS leadership on public health, science, and data policy issues and initiatives. Prior to joining ASPE, Dr. Jones served as senior advisor in the Office of the Commissioner at the US Food and Drug Administration (FDA). Dr. Jones previously led the Centers for Disease Control and Prevention’s (CDC) drug abuse and overdose activities where he focused on strategic policy development and implementation, engaging national and state partners, and conducting research to improve policy and clinical practice.  Dr. Jones has authored more than 50 peer-reviewed publications on the topic of drug abuse and overdose.

Sarah Melton, PharmD, BCCP, BCACP, FASCP
Professor of Pharmacy Practice
Gatton College of Pharmacy-East Tennessee University (ETSU)
Johnson City, TN

In addition to her role at ETSU, Sarah T. Melton is the Clinical Pharmacist at Highpower, PC in Lebanon, Virginia and the Johnson City Community Health Center in Johnson City, TN. She is a recent recipient of the APhA Generation Rx Award of Excellence in recognition of 20 years of dedication to fighting prescription drug abuse and opioid addiction in Appalachia. An advocate for reducing stigma and promoting evidence-based treatment, Melton cares for patients receiving medication-assisted treatment for opioid use disorders. Melton spearheads a partnership between the Tennessee Department of Health and ETSU’s College of Pharmacy to train health care providers and laypeople in naloxone rescue. As a REVIVE! trainer in Virginia, Melton has trained more than 1,500 laypeople and 500 health care providers in naloxone rescue. Melton is Chair of OneCare of Southwest Virginia, a substance abuse collaborative that has trained more than 3,000 health care providers on prescription drug abuse-related issues free of charge

Registration Fees*

Registration is available at and fees are as follows:

Registration Fee

Member: $115
Non-member: $140
Resident/Fellow-Member: $99
Resident/Fellow-Non-member: $124
Student-Member: $99
Student-Non-member: $124

*Early registration fees are available through March 22, 2018. After March 22, 2018, registration fees increase.

Return to The CPNP Perspective issue main page.< Previous Article  Next Article >